Prognostic indications of elevated MCT4 and CD147 across cancer types: a meta‐analysis

CD Bovenzi, J Hamilton, P Tassone… - BioMed research …, 2015 - Wiley Online Library
Background. Metabolism in the tumor microenvironment can play a critical role in
tumorigenesis and tumor aggression. Metabolic coupling may occur between tumor …

[HTML][HTML] MCT4 has a potential to be used as a prognostic biomarker-a systematic review and meta-analysis

A Javaeed, SK Ghauri - Oncology reviews, 2019 - ncbi.nlm.nih.gov
The role of several metabolic changes, such as hypoxia and acidosis, in the tumour
environment has caught the attention of researchers in cancer progression and invasion …

Monocarboxylate transporters 1–4 in NSCLC: MCT1 is an independent prognostic marker for survival

M Eilertsen, S Andersen, S Al-Saad, Y Kiselev… - PloS one, 2014 - journals.plos.org
Introduction Monocarboxylate transporters (MCTs) 1–4 are lactate transporters crucial for
cancers cells adaption to upregulated glycolysis. Herein, we aimed to explore their …

Prognostic value of monocarboxylate transporter 1 overexpression in cancer: a systematic review

A Silva, MC Cerqueira, B Rosa, C Sobral… - International Journal of …, 2023 - mdpi.com
Energy production by cancer is driven by accelerated glycolysis, independently of oxygen
levels, which results in increased lactate production. Lactate is shuttled to and from cancer …

Monocarboxylate transporters in breast cancer and adipose tissue are novel biomarkers and potential therapeutic targets

Z Li, Q Wu, S Sun, J Wu, J Li, Y Zhang, C Wang… - Biochemical and …, 2018 - Elsevier
Monocarboxylate transporters (MCTs) are transmembrane proteins that control the lactate
metabolism and associated with poor prognosis in solid tumours including breast cancer …

Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization

C Pinheiro, V Penna, F Morais-Santos… - Journal of translational …, 2014 - Springer
Abstract Background Soft tissue sarcomas (STSs) are a group of neoplasms, which, despite
current therapeutic advances, still confer a poor outcome to half of the patients. As other …

[HTML][HTML] MCT1 regulates aggressive and metabolic phenotypes in bladder cancer

G Zhang, Y Zhang, D Dong, F Wang, X Ma… - Journal of …, 2018 - ncbi.nlm.nih.gov
Background: Monocarboxylate transporter isoform 1 (MCT1) is an important molecule in
mediating lactate transportation. Recent studies have shown an oncogenic role of MCT1 in …

Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer

A Latif, AL Chadwick, SJ Kitson, HJ Gregson… - BMC clinical …, 2017 - Springer
Background Endometrial cancer (EC) is a major health concern due to its rising incidence.
Whilst early stage disease is generally cured by surgery, advanced EC has a poor prognosis …

Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration

HJ Gao, MC Zhao, YJ Zhang, DS Zhou, L Xu… - Journal of cancer …, 2015 - Springer
Abstract Purpose Monocarboxylate transporter 4 (MCT4) is a critical component in the
glycolytic metabolism of cancer cells, and is also important for malignant behavior. We …

[PDF][PDF] AUTHOR COPY ONLY

F Morais-Santos, V Miranda-Gonçalves… - Endocrine-related …, 2014 - researchgate.net
The tumour microenvironment is known to be acidic due to high glycolytic rates of tumour
cells. Monocarboxylate transporters (MCTs) play a role in extracellular acidification, which is …